1. Adams M, Kerby IJ, Rocker I, Evans A, Johansen K, Franks CR (1987) A comparison of the toxicity and efficacy of cisplatin (CDDP) and carboplatin (JM8) in advanced ovarian cancer. Abstract 785, Proceedings of the 4th European Conference of Clinical Oncology, Madrid 207
2. Anderson H, Wagstaff J, Crowther D, Swindell R, Lind MJ, McGregor J, Timms MS, Brown D, Palmer P (1988) Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer. Eur J Cancer Clin Oncol 24: 1471
3. Atassi G, Kenis Y, Dumont P, Rozencweig M (1983) Animal screening of new platinum derivatives ? studies with single agents and combinations. Abstract 27, Proceedings of the 4th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Br�ssel
4. Barker GH, Wiltshaw E (1981) Randomized trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil and doxorubicin in advanced ovarian carcinoma. Lancet I: 747
5. Bugat R, Martin P, Namer M, Netter-Pinon G, Belpomme D, Dufour P, Naman H, Pouzin K, Sudre-Pinel MC, Chazard M (1987) A pilot study of carboplatin plus cyclophosphamide and doxorubicin in advanced ovarian carcinoma. Abstract 823, Proceedings of the 4th European Conference on Clinical Oncology, Madrid 216